Q4 2021
Released Feb 18, 2022, before the open
10-K filed Feb 24, 2022, 55 days after period end · 0001628280-22-003669
Q4 2021 · 10-K
Revenue$213.13M$213.13M +17.9% vs Q4 2020+7.7% vs Q3 2021
Net Income$24.95M$24.95M +12.6% vs Q4 2020−0.3% vs Q3 2021
EPS Diluted$0.76$0.76 +11.8% vs Q4 2020−1.3% vs Q3 2021
Gross Profit$64,066,000+12.8%
Operating Incomederived$33,821,000+16.9%
Operating Cash Flowderived$44,491,000−7.2%
Free Cash Flowderived$29,917,000−14.9%
Margins · derived
Gross margin30.1%−1.4 pt vs Q4 2020
Operating margin15.9%−0.1 pt vs Q4 2020
Net margin11.7%−0.6 pt vs Q4 2020
What the release said
The release
Same quarter
| Metric | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $213.13M | $180.71M | $166.53M | $163.54M |
| Net Income | $24.95M | $22.16M | $20.38M | $20.33M |
| EPS Diluted | $0.76 | $0.68 | $0.63 | $0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Balchem Corp · CIK 9326 · Engraved from SEC EDGAR